PolyPid Ltd (NAS:PYPD)
$ 3.303 -0.197 (-5.63%) Market Cap: 22.47 Mil Enterprise Value: 25.50 Mil PE Ratio: 0 PB Ratio: 10.01 GF Score: 38/100

Q4 2020 PolyPid Ltd Earnings Call Transcript

Feb 10, 2021 / 01:30PM GMT
Release Date Price: $412.2 (+7.76%)
Operator

Greetings, and welcome to the PolyPid Fourth Quarter and Full Year 2020 Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

I will now like to introduce your host for today's conference, Mr. Bob Yedid from LifeSci Advisors. Mr. Oswald (sic) [Yedid], you may begin.

Robert A. Yedid
LifeSci Advisors, LLC - MD

Thank you all for participating in PolyPid's Fourth Quarter and Full Year 2020 Earnings Conference Call. Joining me on the call today will be Dikla Czaczkes Akselbrad, Executive Vice President and Chief Financial Officer of PolyPid; and Dr. Noam Emanuel, Founder and Chief Scientific Officer.

Earlier today, PolyPid released results for the 3 and 12 months ended December 31, 2020. A copy of the press release is available on the Investors section of the company's website.

I'd like to remind you that on this call, management will make forward-looking statements within the meaning of the federal securities laws. Forward-looking statements are subject to numerous risks and uncertainties, many of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot